Filed Pursuant to Rule 433
Registration Statement No. 333-182852
April 29, 2015
PRICING TERM SHEET
This pricing term sheet supplements, and should be read in conjunction with, Bristol-Myers Squibb Company’s preliminary prospectus supplement dated April 29, 2015 and accompanying prospectus dated July 26, 2012 and the documents incorporated and deemed to be incorporated by reference therein.
| Issuer: | Bristol-Myers Squibb Company | |
| Securities: | 1.000% Notes due 2025 (the “2025 Notes”) 1.750% Notes due 2035 (the “2035 Notes”) | |
| Size: | €575,000,000 2025 Notes €575,000,000 2035 Notes | |
| Maturity Date: | May 15, 2025, with respect to the 2025 Notes May 15, 2035, with respect to the 2035 Notes | |
| Coupon: | 1.000%, with respect to the 2025 Notes 1.750%, with respect to the 2035 Notes | |
| Interest Payment Date: | May 15, commencing May 15, 2016, with respect to the 2025 Notes May 15, commencing May 15, 2016, with respect to the 2035 Notes | |
| Price to Public: | 98.980%, with respect to the 2025 Notes 99.548%, with respect to the 2035 Notes | |
| Benchmark Bund: | 0.500% due February 15, 2025, with respect to the 2025 Notes 4.750% due July 4, 2034, with respect to the 2035 Notes | |
| Spread to Benchmark Bund: | +85.1 bps, with respect to the 2025 Notes +119.4 bps, with respect to the 2035 Notes | |
| Benchmark Bund Price and Yield: | 102.345 and 0.257%, with respect to the 2025 Notes 175.350 and 0.583%, with respect to the 2035 Notes | |
| Yield to Maturity: | 1.108%, with respect to the 2025 Notes 1.777%, with respect to the 2035 Notes | |
| Spread to Mid Swaps: | +53bps, with respect to the 2025 Notes +90bps, with respect to the 2035 Notes | |
| Interpolated Mid Swaps Yield: | 0.578% (10yr Mid Swaps at 0.576% // 11yr Mid Swaps at 0.627%), with respect to the 2025 Notes 0.877% (20yr Mid Swaps at 0.877% // 21yr Mid Swaps at 0.889%), with respect to the 2035 Notes | |
| Optional Redemption: | Make-Whole Rate plus 15 bps, in case of the 2025 Notes Make-Whole Rate plus 20 bps, in case of the 2035 Notes | |
| Underwriting Discount: | 0.450%, with respect to the 2025 Notes 0.650%, with respect to the 2035 Notes | |
| Net Proceeds, after Underwriting Discounts and before Estimated Offering Expenses: | €1,135,211,000 | |
| Trade Date: | April 29, 2015 | |
| Expected Settlement Date (T+3): | May 5, 2015 | |
| Anticipated Ratings: | A2 (Stable) by Moody’s Investors Service, Inc. A+ (Stable) by Standard & Poor’s Ratings Services | |
| Listing: | Application will be made to list the notes on the New York Stock Exchange | |
| Clearing and Settlement: | Euroclear/Clearstream | |
| Stabilization: | Stabilization/FCA | |
| Day Count Convention: | ACTUAL/ACTUAL (ICMA) | |
| CUSIP: | 110122 AY4, in the case of the 2025 Notes 110122 AZ1, in the case of the 2035 Notes | |
| ISIN: | XS1226748439, in the case of the 2025 Notes XS1226748512, in the case of the 2035 Notes | |
| Common Code: | 122674843, in the case of the 2025 Notes 122674851, in the case of the 2035 Notes | |
| Denominations: | €100,000 and integral multiples of €1,000 in excess thereof | |
| Governing Law: | New York | |
| Joint Book-Running Managers: | BNP Paribas Goldman, Sachs & Co. Merrill Lynch International Morgan Stanley & Co. International plc | |
| Co-Managers: | Citigroup Global Markets Limited J.P. Morgan Securities plc Barclays Bank PLC Credit Suisse Securities (Europe) Limited Deutsche Bank AG, London Branch Wells Fargo Securities International Limited HSBC Bank plc Mitsubishi UFJ Securities International plc The Williams Capital Group, L.P. | |
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus and prospectus supplement) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus and prospectus supplement in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer, the underwriters or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by calling BNP Paribas at 1-800-854-5674, Goldman, Sachs & Co. at 1-866-471-2526, Merrill Lynch International at 1-800-294-1322 or Morgan Stanley & Co. International plc at 1-866-718-1649.